Corporate Finance
Wilsons Equity Research
Analyst(s) who own shares in the Company: n/a Issued by Wilsons Advisory and Stockbroking Limited (Wilsons) ABN 68 010 529 665 - Australian Financial Services Licence No 238375, a participant of ASX Group and should be read in conjunction with the disclosures and disclaimer in this report. Important disclosures regarding companies that are subject of this report and an explanation of recommendations can be found at the end of this document.
Theme
Merger / Acquisition
Company
Noni B (NBL)
Date
23 November 2019
Overweight: An easy buy
Noni B Group has acquired 50.1% of EziBuy Limited with the option to
acquire the remaining 49.9% by 31 December 2020 for $11.0m, which
implies an EBITDA multiple of 2.1x. The acquisition provides immediate
online scale, online breadth and online cross-selling opportunities for the
group and as a result management expects online to grow to 20% of sales
by FY20e (annualised). We believe the transaction will also allow the
group to leverage its already attractive gross margins given its extensive
store network resulting in potentially higher online margins than peers.
We believe there is minimal risk to shareholders with this transaction.
OVERWEIGHT.
Key points
Valuation: We move to a DCF base valuation methodology from a blended
methodology previously, given we are comfortable NBL has largely intergraded
the Pretty Girl and SFH acquisitions. As a result, our valuation +9.5% to
$4.20/share which reflects a FY20e PE of 6.5x, -15.2% vs peers.
Earnings: Minor changes to forecasts. EBITDA forecasts +2.3% and +2.3% to
$77.9m and $78.5m in FY20e and FY21e respectively, ahead of guidance for
$75.0m. Our forecasts are 2.6% ahead of consensus in FY20e.
Trading update: Trading remains challenging. Group LFL sales to the end of
October -4% yoy, albeit Noni B brands were traded for cash in 1H19a to
facilitate the SFH acquisition. EBITDA for the first four months of FY20e has
improved $9m yoy ahead of our previous expectations for +$9m in 1H20e
($38.1m).
Transaction: NBL has acquired 50.1% of EziBuy for $1.0 from Alceon, with the
option to acquire the remaining 49.9% on or before 31 December for $11.0m.
While EziBuy is currently break-even (FY19a EBITDA $0.38m) NBL believe it
will be able to achieve cost efficiencies of $8.5m resulting in a FY20e EBITDA
of $5.2m, implying an attractive multiple of 2.11x EBITDA. NBL can sell EziBuy
back to Alceon for $1.00 should it choose to note take up the option. Given the
transaction with with a related party, it is subject to a shareholder vote which is
schedule for 23 December 2019.
Risks and catalysts
Risks: 1) poor response to revised pricing models; 2) rapid decline in broader
retail sales and consumer confidence; and 3) successful succession planning.
Catalysts: 1) announcement of further accretive acquisitions; 2) announcement
of further cost efficiencies; and 3) trading update MYR, CCX or PMV.
Recommendation OVERWEIGHT
12-mth target price (AUD) $4.20
Share price @ 22-Nov-19 (AUD) $2.57
Forecast 12-mth capital return 63.6%
Forecast 12-mth dividend yield 8.9%
12-mth total shareholder return 72.5%
Market cap $249m
Enterprise value $249m
Shares on issue 97m
Sold short 0.0%
ASX 300 weight n/a
Median turnover/day $0.1m John Hynd
Tel. +61 2 8247 6661
12-mth price performance ($)
1-mth 6-mth 12-mth
Abs return (%) -3.0 -2.2 -8.7
Rel return (%) -4.1 -4.5 -27.4
Earnings forecasts
Year-end June (AUD) FY18A FY19A FY20F FY21F FY22F
NPAT rep ($m) 17.6 8.2 37.2 37.8 41.3
NPAT norm ($m) 17.8 9.0 38.1 38.7 42.2
Consensus NPAT ($m) 37.5 40.8 42.6
EPS norm (cps) 21.1 9.4 39.5 40.2 43.8
EPS growth (%) 30.0 -55.6 321.9 1.7 8.9
P/E norm (x) 12.2 27.4 6.5 6.4 5.9
EV/EBITDA (x) 6.7 6.9 3.2 3.2 3.0
FCF yield (%) 8.7 9.4 11.9 19.4 20.4
DPS (cps) 13.0 14.5 23.0 23.5 26.0
Dividend yield (%) 5.1 5.6 8.9 9.1 10.1
Franking (%) 100 100 100 100 100
Source: Company data, Wilsons estimates, S&P Capital IQ
Key changes
28-Aug After Var %
NPAT: FY20F 36.9 38.1 3.2%
norm FY21F 37.5 38.7 3.4%
($m) FY22F 38.7 42.2 9.1%
EPS: FY20F 38.3 39.5 3.2%
norm FY21F 38.9 40.2 3.4%
(cps) FY22F 40.2 43.8 9.1%
DPS: FY20F 23.0 23.0 0.0%
(cps) FY21F 23.5 23.5 0.0%
FY22F 24.0 26.0 8.3%
Price target: 3.84 4.20 9.5%
Rating: O/W O/W
2. 20
2. 55
2. 90
3. 25
3. 60
3. 95
Nov-18 Mar-19 Jul-19 Nov-19
NBL XSI Rebased
23 November 2019
Specialty Retail
Noni B Limited
Wilsons Equity Research
Page 2
Growth rates
Returns
Margin trends
Solvency
Free cash flow yield
Interims ($m)
1H19A 2H19A 1H20E 2H20E
Sales revenue 462.1 402.4 444.7 457.9
EBITDA 23.5 12.6 36.2 41.7
EBIT 12.3 1.4 25.1 29.3
Net profit 9.2 -0.2 17.6 20.4
Norm EPS 9.6 -0.2 18.3 21.2
EBIT/sales (%) 2.7 0.3 5.6 6.4
Dividend (c) 9.0 5.5 11.0 12.0
Franking (%) 100.0 100.0 100.0 100.0
Payout ratio (%) 94.1 <0 60.0 56.5
Adj payout (%) 8.1 <0 15.3 <0
Key assumptions
FY15A FY16A FY17A FY18A FY19A FY20F FY21F FY22F
Revenue Growth (%) -4.0 0.0 187.1 17.6 136.8 4.4 7.9 18.0
EBITDA Growth (%) 424.7 -286.3 295.9 62.4 22.2 71.4 0.8 6.3
EBIT Growth (%) 52.4 -164.0 287.8 94.5 -13.0 134.8 1.1 9.0
NPAT Growth (%) 12.7 -153.6 306.8 79.3 -53.8 357.4 1.8 9.1
EPS Growth (%) 12.7 -144.0 98.8 62.7 -57.7 357.4 1.8 9.1
EBIT / Sales (%) -5.1 3.3 4.4 7.3 2.7 6.0 5.6 5.2
Tax Rate (%) -17.1 -33.6 -21.3 -30.8 -31.5 -30.0 -30.0 -30.0
ROA (%) -15.5 6.5 2.4 7.4 2.0 12.2 11.3 10.8
ROE (%) -53.7 20.2 6.9 16.0 7.7 33.6 29.3 27.6
Financial ratios
FY15A FY16A FY17A FY18A FY19A FY20F FY21F FY22F
PE (x) -18.8 37.4 15.8 12.2 27.4 6.5 6.4 5.9
EV/EBITDA (x) -80.2 43.0 10.9 6.7 6.9 3.2 3.2 3.0
Dividend yield (%) 0.0 0.0 0.0 5.1 5.6 8.9 9.1 10.1
FCF yield (%) 2.1 3.1 13.4 8.7 9.4 11.9 19.4 20.4
Payout ratio (%) 0.0 0.0 0.0 61.6 154.7 58.2 58.4 59.3
Adj payout (%) 0.0 0.0 0.0 44.5 52.7 53.5 48.7 48.4
Profit and loss ($m)
FY15A FY16A FY17A FY18A FY19A FY20F FY21F FY22F
Sales revenue 107.9 107.5 311.5 364.2 864.5 902.7 974.1 1,151.9
EBITDA -3.1 5.8 22.9 37.2 36.0 77.9 78.5 83.4
Depn & amort 2.4 2.3 9.2 10.6 22.3 23.6 23.6 23.6
EBIT -5.5 3.5 13.7 26.6 13.7 54.4 55.0 59.9
Net interest expense -0.1 -0.1 1.2 1.2 1.9 1.2 0.9 0.9
Tax -0.9 1.2 2.7 7.8 3.7 15.9 16.2 17.7
Minorities/pref divs 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Equity accounted NPAT 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Net profit (pre-sig items) -4.5 2.4 9.8 17.6 8.1 37.2 37.8 41.3
Abns/exts/signif 0.0 0.0 -5.5 0.0 0.1 0.0 0.0 0.0
Reported net profit -4.5 2.4 4.3 17.6 8.2 37.2 37.8 41.3
Cash flow ($m)
FY15A FY16A FY17A FY18A FY19A FY20F FY21F FY22F
EBITDA -3.1 5.8 22.9 37.2 36.0 77.9 78.5 83.4
Interest & tax 0.7 0.1 -2.1 -9.3 -17.4 -17.2 -17.1 -18.6
Working cap/other 7.5 1.8 12.6 -6.2 4.8 -9.9 8.5 7.8
Operating cash flow 5.1 7.7 33.4 21.7 23.5 50.8 69.9 72.6
Maintenance capex 0.0 0.0 0.0 0.0 0.0 -21.1 -21.5 -21.9
Free cash flow 5.1 7.7 33.4 21.7 23.5 29.7 48.4 50.7
Dividends paid 0.0 0.0 0.0 -9.7 -12.4 -15.9 -23.6 -24.6
Growth capex -0.3 -3.6 -11.1 -14.2 -8.2 -1.1 -11.5 -0.5
Invest/disposals 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Oth investing/finance flows -1.5 0.6 -37.1 31.9 -57.0 0.0 0.0 0.0
Cash flow pre-financing 3.3 4.6 -14.8 29.7 -54.1 12.8 13.3 25.6
Funded by equity 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Funded by debt -0.1 -0.2 30.0 0.0 32.0 -18.0 0.0 0.0
Funded by cash -3.2 -4.4 -15.2 -29.7 22.1 5.2 -13.3 -25.6
Balance sheet summary ($m)
FY15A FY16A FY17A FY18A FY19A FY20F FY21F FY22F
Cash 8.5 12.9 28.2 58.7 36.6 31.4 44.7 70.3
Current receivables 0.4 1.5 3.7 5.2 5.6 5.0 5.3 6.1
Current inventories 9.9 11.4 29.2 45.5 167.0 114.2 122.4 143.1
Net PPE 5.1 6.4 28.3 32.2 41.1 40.0 50.4 55.2
Intangibles/capitalised 4.9 4.2 90.6 92.6 156.4 156.4 156.4 156.4
Total assets 29.0 37.0 180.7 237.0 411.9 352.2 384.3 436.3
Current payables 14.7 17.7 46.4 59.7 198.6 128.1 140.3 169.9
Total debt 0.2 0.0 22.4 20.4 30.1 13.4 13.4 13.4
Total liabilities 20.7 25.0 118.3 127.0 305.7 224.8 236.1 266.2
Shareholder equity 8.4 12.0 62.4 110.0 106.1 127.4 148.2 170.1
Total funds employed 8.6 12.0 84.8 130.5 136.2 140.8 161.6 183.6
137.4%
4.4% 7.9% 18.3%
-55.6%
321.9%
1.7% 8.9%
FY19A FY20F FY21F FY22F
Revenue Growt h EPS Growt h
21%
8%
33%
28% 27% 29%
11%
36% 34%
36%
FY18A FY19A FY20F FY21F FY22F
ROE ROIC
0%
2%
4%
6%
8%
10%
12%
FY18A FY19A FY20F FY21F FY22F
EBITDA EBIT NPAT
0
20
40
60
80
-45%
-35%
-25%
-15%
-5%
FY18A FY19A FY20F FY21F FY22F
In t.
C o
v e
r (x
)
N e t
D e b t/ E
q u it y
(% )
Net Debt /Equity Interest Cover
8%
12%
16%
20%
24%
FY18A FY19A FY20F FY21F FY22F
Free Cash Flow Yield (%)
23 November 2019
Specialty Retail
Noni B Limited
Wilsons Equity Research
Page 3
Three key points Online growth: NBL’s online sales growth has lagged its industry peers in the last 12-24
months, reaching 9.8% of total sales ($86.4m) in FY19a (CCX 44.0%). Given the
majority of EziBuy’s sales are online (83.4%), we believe this acquisition goes one step
closer to resolving this issue for management and forecast total online sales of $162.5m
in FY20e (17.6% of total revenue). EziBuy should complement NBL’s recent online
additions including MIA Beauty and Carry Ons (earnings immaterial at this stage).
Store strategy: NBL remains committed to its physical store footprint and believes the
broad footprint will be a key driver for achiving its online growth targets. We forecast total
stores of 1,391 in FY21e and 1,397 in FY22e. However, we note NBL has flagged
potential growth of over 100 stores over this period, largely in SFH brands.
Valuation: While our valuation increases 9.5% to $4.20/share (+5.5% under the
previous methodology), should NBL’s new strategy for online growth materialise we
would expect valuation multiples to re-rate. Close peer City Chic (CCX) currently trades
on FY21 PE of 20.0x and Adairs (ADH) currently trades on FY21e PE of 8.7x. While both
companies have different exposures their online businesses are growing strongly and
represent a material proportion of sales. We note the average of the two is 14.4x, well
above NBL’s current FY21e PE of 6.5x.
Changes to forecasts
We have upgraded our NPAT forecasts +0.8% to $38.2m in FY20e, likely marginally ahead
of guidance. Minimal changes were realised at the Interest or Tax line, while a higher D&A
charge for EziBuy offsets the majority of the benefits at the EBITDA line. We assume NBL
retains a 50.1% stake in EziBuy in FY20e.
Revenue: Revenue forecasts increase 6.8% to $902.7m in FY20e, driven by the
consolidation of 50.1% of the EziBuy acquisition. We assume no revenue or cross-
selling synergies at this stage, but make a small change to our LFL calculations which
account for the remaining $14.9m increase in revenue.
EBITDA: EBITDA forecasts increase 2.3% to $1.3m to $77.9m, with some margin
decline due to a marginal impact from EziBuy and adjust for guidance.
Table 1: NBL old vs new forecasts (A$m)
Source: Wilsons estimates
Old New Change Old New Change
Stores 1,385 1,391 0.4% 1,391 1,397 0.4%
Store Revenue 845.3 902.7 6.8% 861.5 974.1 13.1%
LFL grow th 0.0% -3.8% -383 bp 1.0% -0.4% -137 bp
Other 23.2 18.1 -21.8% 23.3 19.0 -18.5%
Total Revenue 868.4 920.8 6.0% 884.8 993.1 12.2%
Gross Prof it 538.8 560.3 4.0% 548.9 596.2 8.6%
Gross Prof it Margin 62.0% 60.8% -119 bp 62.0% 60.0% -200 bp
EBITDA 76.2 77.9 2.3% 76.8 78.5 2.3%
EBITDA margins 8.8% 8.5% -31 bp 8.7% 7.9% -77 bp
D&A 22.3 23.6 5.8% 22.3 23.6 5.8%
EBIT 53.9 54.4 0.8% 54.5 55.0 0.8%
Interest 1.2 1.2 1.3% 1.0 0.9 -7.0%
Tax 15.8 15.9 0.8% 16.1 16.2 1.0%
NPAT 36.9 37.2 0.8% 37.5 37.8 1.0%
FY20 FY21
23 November 2019
Specialty Retail
Noni B Limited
Wilsons Equity Research
Page 4
EziBuy snapshot
Founded in New Zealand in 1978, EziBuy originally sold womenswear and menswear
through catalogue retailing. It now also sells children’s clothing, homewares and gifts.
It is a large Australian and New Zealand multi-channel retailer, which has a customer base of
over 2m and reported NZ$144.6m of revenue in FY19, with 83.4% of sales coming from
online and the annual distribution of ~20m catalogues. Sales in EziBuy’s 6 physical stores
made up 16.6% of total revenue in FY19, an average of NZ$4.0m (A$3.8m) of revenue per
store compared to A$1.2m for Noni B.
In FY19 New Zealand retail sales in the clothing, footwear and accessories segment
represented 4.0% of total retail sales of NZ$3,909m, and demonstrated an increase of +4.4%
yoy. This stands in comparison to Australian clothing, footwear and accessory retail sales of
A$25,445m, which increased 3.3% yoy and represents 7.8% of total retail sales. Australia
currently represents 47.0% of EziBuy’s geographic sales mix and on a pro forma combined
basis Australia will make up 92.3% of group revenue.
Figure 1: EziBuy geographic sales mix Figure 2: EziBuy online/offline sales mix
Source: NBL company data Source: NBL company data
Noni B’s online penetration has historically underperformed peers in the clothing segment.
Despite growth of 21.0% yoy in FY19a, Online sales made up 9.8% of total sales. Noni B’s
closest peer, City Chic Collective, demonstrated Online sales growth of 36% yoy in FY19 and
made up 44.0% of total revenue.
On a pro forma basis, the EziBuy acquisition would increase Noni B’s Online sales to 19.6%
of the sales mix in FY20e, bringing Noni B’s Online sales figure in line with the sector
average of 18.9%.
Figure 3: Revenue segmentation – pro forma EziBuy and Noni B combined
Figure 4: Online revenue segmentation – pro forma EziBuy and Noni B combined
Source: NBL company data Source: NBL company data
Australia, 47.0%
New Zealand, 53.0%
Of f line, 16.6%
Online, 83.4%
EziBuy, 13.3%
Noni B Group, 86.7%
Online, 19.6%
Of f line, 80.4%
23 November 2019
Specialty Retail
Noni B Limited
Wilsons Equity Research
Page 5
Noni B (NBL)
Business description
Noni B Limited (NBL) is a ladies fashion retailer targeting the older, mature demographic (55+ years old) and recently acquired Pretty Girl Pty Ltd
to expand its retail network to more than 650 stores nationwide. Its current brand portfolio consists of Noni B, Rockmans, W.Lane and BeMe.
Investment thesis
Since the Alceon Group’s acquisition of a majority shareholding in NBL in FY15, NBL has recorded significant improvements in gross margins and
has shown early signs of success. In addition to our optimism about management’s experience we are encouraged by its conservative guidance.
Revenue drivers Balance sheet
Consumer confidence
Retail sales
Store rollout
Assets: $197.5m
Equity: $106.1m
Net cash: $6.6m
Margin drivers Board
Selling and distribution costs
Leveraging cost savings from larger store network
Store volumes
Richard Facioni: Chairman and Non-Executive Director
Scott Evans: Chief Executive Officer and Managing Director
Sue Morphet: Non-Executive Director
David Wilshire: Non-Executive Director
Jacqueline Frank: Non-Executive Director
Key issues/catalysts Management
Robust store like-for-like growth
Improved online retail sales
New earnings base
Scott Evans: Chief Executive Officer and Managing Director
Luke Softa: Chief Financial Officer, Secretary
Risk to view Contact details
Poor Mother’s Day trading period
Aggressive discounting by peers
Rapid decline in broader retail sales and consumer confidence
Address: Ground Floor, 61 Dunning Avenue, Rosebery, NSW 2018
Phone: +61 2 8577 7777
Website: www.nonib.com.au
23 November 2019
Specialty Retail
Noni B Limited
Wilsons Equity Research
Page 6
Disclaimers and disclosures
Recommendation structure and other definitions
Definitions at wilsonsadvisory.com.au/Disclosures.
Disclaimer
This document has been prepared by Wilsons Advisory and Stockbroking Limited (ACN 010 529 665: AFSL 238375) (“Wilsons”). This communication is not to be
disclosed in whole or part or used by any other party without Wilsons’ prior written consent.
This document is being supplied to you solely for your information and no action should be taken on the basis of or in reliance on this document. Any advice contained in
this document is general advice only and has been prepared by Wilsons without taking into account any person’s objectives, financial situation or needs. Any person,
before acting on any advice contained within this communication, should first consult with a Wilsons investment adviser to assess whether the advice within this
communication is appropriate for their objectives, financial situation and needs. Those acting upon such information without advice do so entirely at their own risk.
Wilsons has not independently verified all of the information given in this document which is provided at a point in time and may not contain all necessary information
about the company or companies covered in this report (“Companies”). Accordingly, no representation or warranty, express or implied, is made as to the accuracy or
completeness of the information and opinions contained in this document. To the fullest extent permitted by law Wilsons, its related bodies corporate and their respective
officers, directors, employees or agents, disclaim any and all liabilities for any loss or damage howsoever arising in connection with the use of this document or its
contents. Any projections contained in this document are indicative estimates only. Such projections are contingent upon matters outside the control of Wilsons
(including but not limited to economic conditions, market volatility and company-specific fundamentals) and therefore may not be realised in the future. Past performance
is not an indication of future performance.
This report does not constitute an offer or invitation to purchase any securities and should not be relied upon in connection with any contract or commitment whatsoever.
Wilsons and Wilsons Corporate Finance Limited (ABN 65 057 547 323: AFSL 238 383) and their associates may have received and may continue to receive fees from
the Companies in relation to corporate advisory, underwriting or other professional investment services. Please see relevant Wilsons disclosures at
wilsonsadvisory.com.au/Disclosures.
Neither Wilsons nor its research analysts received any direct financial or non-financial benefits from the Companies for the production of this document. However,
Wilsons’ research analysts may receive assistance from the Company in preparing their research which may include attending site visits and/or meetings hosted by the
Companies. In some instances the costs of such site visits or meetings may be met in part or in whole by the Companies if Wilsons considers it is reasonable given the
specific circumstances relating to the site visit or meeting.
Wilsons and its related bodies may trade securities in the Companies as principal.
Regulatory disclosures
Wilsons restricts research analysts from trading in securities for which they write research. Other Wilsons employees may hold interests in the company, but none of
those interests are material. Wilsons further advises that at the date of this report, neither Wilsons Advisory and Stockbroking Limited or Wilsons Corporate Finance
Limited have any material interests in the company. <br><br>Wilsons Corporate Finance Limited ACN 057 547 323, AFSL 238 383 acted as Lead Manager and
Underwriter in the May 2018 placement and entitlement offer of Noni B Limited securities and Financial Advisor on the November 2019 acquisition of EziBuy Limited for
which it received fees or will receive fees for acting in this capacity. Wilsons Advisory and Stockbroking Limited may have a conflict of interest which investors should
consider before making an investment decision. Wilsons Advisory and Stockbroking Limited, Wilsons Corporate Finance Limited and its related bodies corporate trades
or may trade as principal in the securities that are subject of the research report.<br><br>Wilsons Advisory and Stockbroking Limited has been appointed by Noni B
(NBL.ASX) to act as its broker for the on-market buy-back of NBL.ASX ordinary shares.<br><br>This report was prepared solely by Wilsons Advisory and Stockbroking
Limited. ASX did not prepare any part of the report and has not contributed in any way to its content. The role of ASX in relation to the preparation of the research reports
is limited to funding their preparation, by Wilsons Advisory and Stockbroking Limited, in accordance with the ASX Equity Research Scheme. ASX does not provide
financial product advice. The views expressed in this research report may not necessarily reflect the views of ASX. To the maximum extent permitted by law, no
representation, warranty or undertaking, express or implied, is made and no responsibility or liability is accepted by ASX as to the adequacy, accuracy, completeness or
reasonableness of the research reports.<br>
Wilsons contact
For more information please phone: 1300 655 015 or email: [email protected]